Effect of Left Erector Spinae Plane Block on Left Ventricular Functions
Launched by AYDIN ADNAN MENDERES UNIVERSITY · Jan 7, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a specific type of pain relief method called the left thoracic erector spinae plane (ESP) block on the heart's function, particularly the left ventricle, which is an important part of the heart that pumps blood to the body. Researchers want to see if this block, similar to another method called thoracic epidural anesthesia, can affect how well the heart works. They will use a special ultrasound called transthoracic echocardiography (TTE) to assess heart function in patients.
If you are between 18 and 75 years old and are scheduled for elective surgery on the left side of your chest, you may be eligible to participate in this study. However, there are some reasons you might not be able to join, such as if you have certain medical conditions, are taking specific medications, or if you have an infection at the injection site. Participants in the trial can expect to receive the left thoracic ESP block as part of their surgery and will have their heart function monitored through ultrasound before and after the procedure. This research aims to better understand how this pain relief method may influence heart function during surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing elective left-sided thoracic surgery ASA I-III 18-75 years of age
- Exclusion Criteria:
- • 1. Refusal at enrollment
- • 2. Request for withdrawal from the study
- • 3. Inability to give informed consent
- • 4. Emergency surgery
- • 5. Bleeding diathesis
- • 6. Presence of contraindications to the LA agents used in this study
- • 7. Use of chronic opioids
- • 8. Psychiatric disorders
- • 9. Presence of infection at the injection site
About Aydin Adnan Menderes University
Aydin Adnan Menderes University is a leading academic institution based in Turkey, renowned for its commitment to advancing medical research and education. The university actively sponsors clinical trials that aim to explore innovative therapeutic approaches and enhance patient care. With a multidisciplinary team of experts, state-of-the-art facilities, and a dedication to ethical research practices, Aydin Adnan Menderes University fosters a collaborative environment that supports the development of groundbreaking medical solutions, ultimately aiming to improve health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported